Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.27 USD
Change Today +0.32 / 4.03%
Volume 1.5M
As of 5:20 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Garo H. Armen Ph.D.

Founder, Executive Chairman, Chief Executive Officer and Chairman of Business & Development Advisory Committee, Agenus Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 4 different organizations across 4 different industries.

See Board Relationships
61$2,283,529
As of Fiscal Year 2014

Background*

Dr. Garo H. Armen, Ph.D. has been the Founder and Chief Executive Officer of Agenus Inc. since 1994 and serves as its Chairman. Dr. Armen served as President of Antigenics since January 2002. Prior to Agenus Inc., he established Armen Partners, a money management firm specializing in biotechnology and pharmaceutical companies, and was the architect of the widely publicized creation of the Immunex Lederle oncology business in 1993. Since 1990, Dr. Armen served as the ...

Read Full Background

Corporate Headquarters*

3 Forbes Road
Lexington, Massachusetts 02421

United States

Phone: 781-674-4400
Fax: 781-674-4200

Board Members Memberships*

Chairman of the Board
Chairman
1994-2006
Former Non Executive Director
1998-Present
Director and Member of Compensation Committee
1999-Present
Founder, Executive Chairman, Chief Executive Officer and Chairman of Business & Development Advisory Committee

Education*

PhD
The City University of New York

Other Affiliations*

Annual Compensation*

Salary$502,360
Total Annual Compensation$502,360

Stock Options*

All Other Compensation$24,956
Exercisable Options1,003,140
Exercisable Options Value$345,450
Unexercisable Options564,262
Unexercisable Options Value$459,248
Total Value of Options$804,698
Total Number of Options1,567,402

Total Compensation*

Total Annual Cash Compensation$947,316
Total Short Term Compensation$502,360
Other Long Term Compensation$24,956
Total Calculated Compensation$2,283,529
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGEN:US $8.27 USD +0.32

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGENUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.